BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10072632)

  • 1. C1q knock-out mice for the study of complement deficiency in autoimmune disease.
    Botto M
    Exp Clin Immunogenet; 1998; 15(4):231-4. PubMed ID: 10072632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.
    Botto M; Dell'Agnola C; Bygrave AE; Thompson EM; Cook HT; Petry F; Loos M; Pandolfi PP; Walport MJ
    Nat Genet; 1998 May; 19(1):56-9. PubMed ID: 9590289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus].
    Trendelenburg M; Schifferli JA
    Z Rheumatol; 2000 Jun; 59(3):172-5. PubMed ID: 10929445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice.
    Pickering MC; Fischer S; Lewis MR; Walport MJ; Botto M; Cook HT
    J Invest Dermatol; 2001 Jul; 117(1):52-8. PubMed ID: 11442749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic lupus erythematosus, complement deficiency, and apoptosis.
    Pickering MC; Botto M; Taylor PR; Lachmann PJ; Walport MJ
    Adv Immunol; 2000; 76():227-324. PubMed ID: 11079100
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance.
    Roumenina LT; Sène D; Radanova M; Blouin J; Halbwachs-Mecarelli L; Dragon-Durey MA; Fridman WH; Fremeaux-Bacchi V
    J Immunol; 2011 Oct; 187(8):4369-73. PubMed ID: 21930969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.
    Robson MG; Cook HT; Botto M; Taylor PR; Busso N; Salvi R; Pusey CD; Walport MJ; Davies KA
    J Immunol; 2001 Jun; 166(11):6820-8. PubMed ID: 11359841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against C1q in patients with systemic lupus erythematosus.
    Trendelenburg M
    Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited.
    Korb LC; Ahearn JM
    J Immunol; 1997 May; 158(10):4525-8. PubMed ID: 9144462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Structure and function of complement protein C1q and its role in the development of autoimmune diseases].
    Smykał-Jankowiak K; Niemir ZI
    Postepy Hig Med Dosw (Online); 2009 Apr; 63():134-41. PubMed ID: 19373194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance.
    Navratil JS; Korb LC; Ahearn JM
    Immunopharmacology; 1999 May; 42(1-3):47-52. PubMed ID: 10408365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q deficiency and autoimmunity: the effects of genetic background on disease expression.
    Mitchell DA; Pickering MC; Warren J; Fossati-Jimack L; Cortes-Hernandez J; Cook HT; Botto M; Walport MJ
    J Immunol; 2002 Mar; 168(5):2538-43. PubMed ID: 11859149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency.
    Topaloglu R; Bakkaloglu A; Slingsby JH; Aydintug O; Besbas N; Saatci U; Walport MJ
    Clin Exp Rheumatol; 2000; 18(1):75-7. PubMed ID: 10728448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MafB is a critical regulator of complement component C1q.
    Tran MTN; Hamada M; Jeon H; Shiraishi R; Asano K; Hattori M; Nakamura M; Imamura Y; Tsunakawa Y; Fujii R; Usui T; Kulathunga K; Andrea CS; Koshida R; Kamei R; Matsunaga Y; Kobayashi M; Oishi H; Kudo T; Takahashi S
    Nat Commun; 2017 Nov; 8(1):1700. PubMed ID: 29167450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Links between complement deficiency and apoptosis.
    Botto M
    Arthritis Res; 2001; 3(4):207-10. PubMed ID: 11438036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary C1q deficiency and systemic lupus erythematosus.
    Bowness P; Davies KA; Norsworthy PJ; Athanassiou P; Taylor-Wiedeman J; Borysiewicz LK; Meyer PA; Walport MJ
    QJM; 1994 Aug; 87(8):455-64. PubMed ID: 7922299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.